Navigation Links
SeqWright's Partnership With Third Wave Contributes to FDA Success
Date:3/31/2008

HOUSTON, March 31 /PRNewswire/ -- SeqWright Inc. today congratulated Third Wave Technologies Inc., Madison, Wis., on the successful FDA clearance of its InPlex(TM) CF Molecular Test. CLIA-certified SeqWright is a leader in the field of contract genomics and provided the FDA-level genotyping that ultimately validated the InPlex(TM) CF test by demonstrating it had 99.96% overall agreement with DNA sequencing. The validation played a critical role in the test gaining FDA clearance. SeqWright was responsible for providing the sequence verification for 19 cystic fibrosis (CF) variants from numerous patient samples.

The success of SeqWright's collaboration with Third Wave builds on a relationship established in 2004, when the two companies began work on Third Wave's UGT1A1 Molecular Assay. SeqWright provided FDA-level sequencing to validate the UGT1A1 pharmacogenetic test, which is used to identify patients susceptible to adverse reaction from a specific colorectal cancer treatment. The assay gained FDA clearance in August 2005. SeqWright was selected for the sequencing-based validation of Third Wave's InPlex(TM) CF test after the exemplary work it performed with Third Wave's UGT1A1 Molecular Assay.

"We are grateful for the contributions SeqWright has made to Third Wave's two successful FDA submissions," said Kevin T. Conroy, president and chief executive of Third Wave.

SeqWright CEO, Fei Lu, M.D., said, "We are proud of the success of our past and present collaborations with Third Wave Technologies and we are excited to be involved in the validation of these important diagnostic tests."

About SeqWright:

SeqWright Incorporated is a world-class genomic services support organization based in Houston, TX with more than a decade of experience specializing in providing access to state of the art Molecular Biology and Genomic services in a highly regulated GLP/CLIA environment. For additional information about SeqWright and its services
'/>"/>

SOURCE SeqWright Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
2. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
3. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
4. B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership
5. NASN Joins Partnership to Fight Chronic Disease
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
8. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
9. Partnership to Fight Chronic Disease Announces Ideas for Change in Health Care
10. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
11. Anthem Blue Cross and Blue Shield Partnership Plan Wins Nevada Immunization Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... 5 The first Football,for Hope Centre in ... its doors,today (5 December 2009). FIFA President Joseph ... Zille, 2010 FIFA World Cup Organising Committee,South Africa ... Kirsten Nematandani and Executive Mayor of the City ...
(Date:12/5/2009)... advanced Technology Center helps companies develop and test their cleaning processes. ... a variety of industries and solve problems for customers relating to ... ... December 5, 2009 -- Midbrook, Inc , a Jackson, MI-based ...
(Date:12/4/2009)... Investment Trust Inc. (NYSE: CRE ) ("Care" or ... a dividend of $0.17 per share of common stock. The ... record on December 14, 2009. ,, About ... real estate investment and finance company investing in healthcare-related real estate ...
(Date:12/4/2009)... Healthcare Trust of America, Inc. ("HTA"), a self-managed, ... a purchase and sale agreement to acquire a three ... Corsicana, Texas, and Fort Wayne, Indiana for approximately $20,500,000. ... the satisfaction of a number of conditions. ,, The ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 In response to ... (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione ... Act (CSA), John Gay, executive director and ... the oldest and largest trade association ...
Breaking Medicine News(10 mins):Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
... Scientific and Industrial Research Organization (CSIRO) may increase ... Stanton, Nutritionist. //Dr. Stanton has asked the Australian ... involved in recommending CSIRO diet as it contains ... to recommend the Australian Governments Australian Guide to ...
... of AIDS patients being robbed off their pockets to pay ... the service based health care system, // believed to prevail ... no AIDS related symptoms when she was admitted to the ... ensured prompt medical attention at the time of admission. She ...
... primary diseases affecting the children below two years. It is ... end of November and the incidence increases and reaches a ... MD, associate director of pediatric infectious diseases and HIV at ... the disease and this situation has to change. ...
... health in the UK could be hit by a shortage ... primary care reforms mean stalling of their careers and withdrawal ... trust mergers in England under Commissioning a Patient-led NHS has ... ,BMA public health doctors estimate as many as ...
... been named America's fittest city by Men's Fitness magazine, and ... the Men's Fitness magazine,// the top fittest cities behind Baltimore ... fattest cities behind Chicago were Las Vegas, Los Angeles, Dallas ... was ranked as the 25th fittest city on a list ...
... least five people-three in Ankara and two in Van-have tested positive ... Turkish official said on Sunday. They are on treatment.// ... the press that so far 28 people were tested at a ... total number of people infected with H5N1, the most virulent form ...
Other Medicine News:Health News:AIDS Patients Deceived By Private Health Care System In China 2Health News:Parental Knowledge Of RSV Infections Is Vital 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense ... announced today the presentation of new data from the ... Protective Antigen (rPA) based anthrax vaccine is structurally stable ... to and including 55 degrees C. The data ...
(Date:12/4/2009)... cans and car trunks ,, WASHINGTON, Dec. 4 ... to defeat the Dorgan Importation plan encompassed in SA 2793. ... poised to open our borders, allowing our safe, closed drug ... We could soon be getting drugs that were stored ...
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5MDMA Board Unanimously Opposes Medical Device Tax 5366 1MDMA Board Unanimously Opposes Medical Device Tax 5366 2Body Clock Blood Sugar Control Seem Linked 59234 1Body Clock Blood Sugar Control Seem Linked 59234 276 Children Dead From Swine Flu 3A CDC 59232 176 Children Dead From Swine Flu 3A CDC 59232 276 Children Dead From Swine Flu 3A CDC 59232 3
... Va., April 30 Innocoll, Inc., a ... three planned phase 2,clinical trials sponsored by ... investigate CollaRx(R) GENTAMICIN TOPICAL for the,treatment and ... commenced,dosing. CollaRx GENTAMICIN TOPICAL is a biodegradable ...
... CITY, Calif., April 29 Cardica, Inc.,(Nasdaq: ... Anastomosis,System achieved its primary endpoint in a large, ... made using the,PAS-Port system to conventional hand-sewn sutures ... the positive data from the trial,Cardica submitted a ...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections 4Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 2Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 3Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery 4
1.0 mm long 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
Angled for easy insertion into side port incision for manipulation of nucleus. Flat, paddle like tip for placement in groove to crack the nucleus for emulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: